139O Final results of the double-blind placebo (PBO)-controlled randomised phase II LOTUS trial of first-line ipatasertib (IPAT) + paclitaxel (PAC) for inoperable locally advanced/metastatic triple-negative breast cancer (mTNBC)

Rebecca Dent, Mafalda Oliveira, Steven J. Isakoff, S-A. Im, Marc Espié, Sibel Blau, Antoinette R. Tan, Cristina Saura, Matthew Wongchenko, N. Xu, Denise Bradley, S-J. Reilly, Aruna Mani, S-B. Kim